Evidence map›Paper›PMID 37602191›Full record

ArticleFrontiers in molecular neuroscience2023

AMPA and GABAA receptor nanodomains assemble in the absence of synaptic neurotransmitter release.

Harrison J Ramsay, Sara E Gookin, Austin M Ramsey, Dean J Kareemo, Kevin C Crosby, Dominik G Stich, Samantha S Olah, Hannah S Actor-Engel, Katharine R Smith, Matthew J Kennedy

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Harrison J RamsayAnschutz Medical Campus, Department of Pharmacology, University of Colorado, Aurora, CO, United States.
Sara E GookinAnschutz Medical Campus, Department of Pharmacology, University of Colorado, Aurora, CO, United States.
Austin M RamseyAnschutz Medical Campus, Department of Pharmacology, University of Colorado, Aurora, CO, United States.
Dean J KareemoAnschutz Medical Campus, Department of Pharmacology, University of Colorado, Aurora, CO, United States.
Kevin C CrosbyAnschutz Medical Campus, Department of Pharmacology, University of Colorado, Aurora, CO, United States.
Dominik G StichAnschutz Medical Campus, Advanced Light Microscopy Core, University of Colorado, Aurora, CO, United States.
Samantha S OlahAnschutz Medical Campus, Department of Pharmacology, University of Colorado, Aurora, CO, United States.
Hannah S Actor-EngelAnschutz Medical Campus, Department of Pharmacology, University of Colorado, Aurora, CO, United States.
Katharine R SmithAnschutz Medical Campus, Department of Pharmacology, University of Colorado, Aurora, CO, United States.
Matthew J KennedyAnschutz Medical Campus, Department of Pharmacology, University of Colorado, Aurora, CO, United States.
University of Colorado Anschutz Medical Campus · US

Funding

Novel approaches for interrogating and manipulating synaptic function, structure and plasticityR35NS116879 · NINDS · UNIVERSITY OF COLORADO DENVER · PI Matthew J Kennedy · 2020 to 2026
$4.0M
Nanoscale organization of the inhibitory synapse during synaptic plasticityR01MH119154 · NIMH · UNIVERSITY OF COLORADO DENVER · PI SMITH, KATHARINE RACHEL · 2020 to 2024
$2.0M
Validating and extending optical tools for extended neural silencingUF1NS107710 · NINDS · UNIVERSITY OF COLORADO DENVER · PI FORD, CHRISTOPHER PETER, KENNEDY, MATTHEW J · 2018 to 2018
$2.0M
NIMH NIH HHS R01 MH119154NINDS NIH HHS R35 NS116879NINDS NIH HHS UF1 NS107710
6 · The paper itself

Abstract

Postsynaptic neurotransmitter receptors and their associated scaffolding proteins assemble into discrete, nanometer-scale subsynaptic domains (SSDs) within the postsynaptic membrane at both excitatory and inhibitory synapses. Intriguingly, postsynaptic receptor SSDs are mirrored by closely apposed presynaptic active zones. These trans-synaptic molecular assemblies are thought to be important for efficient neurotransmission because they concentrate postsynaptic receptors near sites of presynaptic neurotransmitter release. While previous studies have characterized the role of synaptic activity in sculpting the number, size, and distribution of postsynaptic SSDs at established synapses, it remains unknown whether neurotransmitter signaling is required for their initial assembly during synapse development. Here, we evaluated synaptic nano-architecture under conditions where presynaptic neurotransmitter release was blocked prior to, and throughout synaptogenesis with tetanus neurotoxin (TeNT). In agreement with previous work, neurotransmitter release was not required for the formation of excitatory or inhibitory synapses. The overall size of the postsynaptic specialization at both excitatory and inhibitory synapses was reduced at chronically silenced synapses. However, both AMPARs and GABA

Indexed as

AMPA receptorexcitatoryGABA receptorinhibitorynanodomainneurotransmitter releasepostsynaptic neurotransmitter receptorsSynapse

Identifiers

PMID37602191
PMCPMC10435253
OpenAlexW4385547864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.